Literature DB >> 3027126

Human giant cell tumors of bone identification and characterization of cell types.

S R Goldring, M S Roelke, K K Petrison, A K Bhan.   

Abstract

Cells cultured from human giant cell tumors of bone were characterized on the basis of morphological features, proliferative capacity, presence of granulocyte-monocyte antigens, receptors for skeletal hormones, and soluble cell products. Three major cell types were identified. One population consisted of mononuclear cells with fibroblastic morphology, which proliferated in culture and most likely represent the neoplastic element of the tumor. Phenotypically they resembled a connective tissue stromal cell. A second population of mononuclear cells lacked receptors for skeletal hormones and did not persist in culture. These cells were likely of monocyte-macrophage lineage. A third population of cells consisted of large multinucleated giant cells. These cells possessed phenotypic features of osteoclasts including receptors for calcitonin. Human giant cell tumors of bone are most likely a neoplasm of connective tissue stromal cells, which have the capacity to recruit and interact with multinucleated giant cells that exhibit phenotypic features of osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027126      PMCID: PMC424109          DOI: 10.1172/JCI112838

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  A cell strain cultured from porcine kidney increases cyclic AMP content upon exposure to calcitonin or vasopressin.

Authors:  S R Goldring; J M Dayer; D A Ausiello; S M Krane
Journal:  Biochem Biophys Res Commun       Date:  1978-07-28       Impact factor: 3.575

2.  Giant cell tumor of bone. The role of the giant cell in orthopedic pathology.

Authors:  J Johnston
Journal:  Orthop Clin North Am       Date:  1977-10       Impact factor: 2.472

3.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

Authors:  G C Nicholson; J M Moseley; P M Sexton; F A Mendelsohn; T J Martin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

5.  Giant-cell tumor of bone. An analysis of two hundred and eighteen cases.

Authors:  R R Goldenberg; C J Campbell; M Bonfiglio
Journal:  J Bone Joint Surg Am       Date:  1970-06       Impact factor: 5.284

6.  Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma.

Authors:  V S Byers; A S Levin; J O Johnston; A J Hackett
Journal:  Cancer Res       Date:  1975-09       Impact factor: 12.701

Review 7.  Characterization of cells from human giant cell tumors of bone.

Authors:  S R Goldring; A L Schiller; H J Mankin; J M Dayer; S M Krane
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

8.  Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte-macrophage lineage antigens.

Authors:  G R Burmester; R J Winchester; A Dimitriu-Bona; M Klein; G Steiner; H A Sissons
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

9.  Photoaffinity labeling of parathyroid hormone receptors: comparison of receptors across species and target tissues and after desensitization to hormone.

Authors:  S R Goldring; G A Tyler; S M Krane; J T Potts; M Rosenblatt
Journal:  Biochemistry       Date:  1984-01-31       Impact factor: 3.162

10.  Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types.

Authors:  M A Horton; E F Rimmer; D Lewis; J A Pringle; K Fuller; T J Chambers
Journal:  J Pathol       Date:  1984-12       Impact factor: 7.996

View more
  40 in total

1.  Differential gene expression in stromal cells of human giant cell tumor of bone.

Authors:  M Wuelling; G Delling; E Kaiser
Journal:  Virchows Arch       Date:  2004-09-23       Impact factor: 4.064

Review 2.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

Review 3.  Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

4.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Authors:  L Huang; J Xu; D J Wood; M H Zheng
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

5.  Collagenase expression and activity in the stromal cells from giant cell tumour of bone.

Authors:  Robert W Cowan; Isabella W Y Mak; Nigel Colterjohn; Gurmit Singh; Michelle Ghert
Journal:  Bone       Date:  2009-02-12       Impact factor: 4.398

6.  In vitro bone resorption by isolated multinucleated giant cells from giant cell tumour of bone: light and electron microscopic study.

Authors:  J Kanehisa; T Izumo; M Takeuchi; T Yamanaka; T Fujii; H Takeuchi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Histogenetic characterization of giant cell tumor of bone.

Authors:  Manuela Salerno; Sofia Avnet; Marco Alberghini; Armando Giunti; Nicola Baldini
Journal:  Clin Orthop Relat Res       Date:  2008-06-10       Impact factor: 4.176

8.  Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts.

Authors:  S R Goldring; M L Stephenson; E Downie; S M Krane; J H Korn
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

9.  The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004).

Authors:  Jennifer L Beebe-Dimmer; Karynsa Cetin; Jon P Fryzek; Scott M Schuetze; Kendra Schwartz
Journal:  Rare Tumors       Date:  2009-12-28

10.  Role of the VEGF-Flt-1-FAK pathway in the pathogenesis of osteoclastic bone destruction of giant cell tumors of bone.

Authors:  Yoshihiro Matsumoto; Yuko Okada; Jun-Ichi Fukushi; Satoshi Kamura; Toshifumi Fujiwara; Keiichiro Iida; Mihoko Koga; Shuichi Matsuda; Katsumi Harimaya; Akio Sakamoto; Yukihide Iwamoto
Journal:  J Orthop Surg Res       Date:  2010-11-09       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.